Natixis’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$80 | – | 1092 |
|
|
2024
Q3 | $80 | Hold |
1
| – | – | ﹤0.01% | 921 |
|
|
2024
Q2 | $83 | Hold |
1
| – | – | ﹤0.01% | 950 |
|
|
2024
Q1 | $85 | Buy |
+1
| New | +$85 | ﹤0.01% | 959 |
|
|
2021
Q1 | – | Sell |
-2,795
| Closed | -$332K | – | 1114 |
|
|
2020
Q4 | $332K | Sell |
2,795
-964
| -26% | -$115K | ﹤0.01% | 945 |
|
|
2020
Q3 | $328K | Sell |
3,759
-1,289
| -26% | -$112K | ﹤0.01% | 650 |
|
|
2020
Q2 | $452K | Sell |
5,048
-46
| -0.9% | -$4.12K | ﹤0.01% | 627 |
|
|
2020
Q1 | $508K | Sell |
5,094
-4,626
| -48% | -$461K | ﹤0.01% | 569 |
|
|
2019
Q4 | $1.11M | Buy |
9,720
+1,519
| +19% | +$174K | 0.01% | 643 |
|
|
2019
Q3 | $1.03M | Buy |
8,201
+990
| +14% | +$125K | 0.01% | 587 |
|
|
2019
Q2 | $868K | Sell |
7,211
-2,512
| -26% | -$302K | 0.01% | 554 |
|
|
2019
Q1 | $833K | Sell |
9,723
-91
| -0.9% | -$7.8K | 0.01% | 610 |
|
|
2018
Q4 | $982K | Buy |
9,814
+574
| +6% | +$57.4K | 0.01% | 518 |
|
|
2018
Q3 | $1.06M | Sell |
9,240
-5,397
| -37% | -$619K | 0.01% | 563 |
|
|
2018
Q2 | $1.31M | Sell |
14,637
-699
| -5% | -$62.7K | 0.01% | 574 |
|
|
2018
Q1 | $1.12M | Buy |
15,336
+2,886
| +23% | +$211K | 0.01% | 573 |
|
|
2017
Q4 | $723K | Sell |
12,450
-908
| -7% | -$52.7K | 0.01% | 547 |
|
|
2017
Q3 | $599K | Buy |
+13,358
| New | +$599K | 0.01% | 619 |
|
|
2017
Q2 | – | Sell |
-5,684
| Closed | -$231K | – | 886 |
|
|
2017
Q1 | $231K | Buy |
5,684
+109
| +2% | +$4.43K | ﹤0.01% | 834 |
|
|
2016
Q4 | $224K | Buy |
+5,575
| New | +$224K | ﹤0.01% | 765 |
|